Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
To guide our collaborative, globe-spanning alliance, GA4GH relies on a Standards Steering Committee and an Executive Committee.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across four Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
27 Aug 2020
On episode 9 of the OmicsXchange podcast, we speak with Laura Paglione — Co-Lead of the GA4GH Equity, Diversity, and Inclusion (EDI) Advisory Group — on amplifying underrepresented voices within the genomics and health data community.
Angela Page: Welcome to the OmicsXchange, I’m Angela Page. Today I’m speaking with Laura Paglione, a partner at Spherical Cow Group, which provides identity management and consulting services for higher education, research, virtual organizations, and enterprise. Laura first got involved with GA4GH as the founding technical director of ORCID, which provides unique identifiers for individuals in research scholarship and innovation. A long time member of the Data Use and Researcher Identities Work Stream, Laura now also co-leads the GA4GH Equity, Diversity, and Inclusion (EDI) Advisory Group helping to amplify underrepresented voices in the Genomics and Health Data Community. Welcome Laura.
Laura Paglione: Thanks, Angela. I’m really excited to be here.
Angela Page: So tell me a little bit about your new role within the EDI and what you’ve been working on.
Laura Paglione: The purpose of the group is to support GA4GH in its mission to create truly global standards for genomic and health data sharing. So this means finding equitable and inclusive ways to bring diverse ideas to our standards creation processes. And that includes identifying opportunities to attract diverse talent to the GA4GH standards community, it includes helping new and existing contributors from all sorts of backgrounds to feel welcome in the community and have opportunities to contribute to the work. And finally, it includes ensuring that the outwardly facing opportunities like leadership and speaking opportunities also reflect the breadth of that diversity that we’ve built in the community.
Angela Page: This discussion around diversity and inclusion, and encouraging a truly global community, is critical when we’re talking about genomic and health data.
Laura Paglione: I think I think the case for diversity in genomics data has gotten a lot of attention lately. The COVID-19 pandemic has increased the attention to the consequences of long standing gaps in population understanding, inclusion and research, and access to targeted care. Without the policies that address diversity in genomic and health data collection use, we face risks in the data not informing the scientific research that may lead to the population-relevant screening guidelines, diagnostics, and treatments. Or the data may be used by and primarily benefit outside parties over the societal benefits as a whole. Without policies that address diversity in genomics in health data collection and use, we may inadvertently slow down adoption of advancing health care approaches that can improve patient care pathways. Very often we talk about diversity, it’s easier to talk about diversity in terms of numbers. You know, like how many people of color do we have? How many women do we have? How many from Africa do we have? It’s so easy, you can quantify that really simply. But it’s kind of beside the point. If you have a diverse community that’s actually contributing their own viewpoints and everyone is listening to them, the result is going to be better. It’s going to ensure that you have better innovation, that you have better problem solving because you’re’ considering a broader set of considerations in what you’re thinking about. It can lead to more ethical management. So there’s so much gained by having a diverse group that’s working together in order to solve something, especially something so important as how we use people’s health data in order to address global concerns in how people stay healthy. I don’t see that there’s any other way to do the work.
Angela Page: So just to clarify, diversity within genomic data itself is not the primary focus of the EDI. The EDI is focusing on incorporating diverse perspectives in the development of standards for genomic data—why is this an important distinction?
Laura Paglione: Well, I think it’s almost impossible to enable diversity in genomics and health and data if the community of individuals that are writing the standards to enable that data exchange, or defining criteria for access or ethical use of the data are not in themselves also diverse. In June 2020, the World Economic Forum released a white paper outlining a genomics data policy framework and highlighting ethical tensions in doing the work. And in their framing, they mentioned that their paper is written with a focus on low and middle income countries in emerging economies. And they point out that they’re doing so not to imply that there should be a different standard among countries. But rather, they want to ensure that the consideration of the differing perspectives and needs informed by these countries diverse, historical, societal, and cultural contexts are included. And they also, in writing the paper, aim to keep the interest of research participants and patients at the forefront of the policy and ethical considerations. And they do that because they argue that their inclusion in the discussion and development and approaches to the genomic data collection and use would likely prevent numerous blind spots as well as conflicts and sources of mistrust, while also fostering understanding and better outcomes. And the underlying goals of the EDI advisory group come from a similar idea. If our community is not diverse, we face the very real possibility that our work will miss the mark of accelerating progress in genomics research and human health, because our standards won’t work in all situations, and our harmonized approaches won’t work for all that we seek to include.
Angela Page: That’s a great explanation. So, how is the EDI group framing its approaches to advance its goals?
Laura Paglione: So several years ago, I heard a talk by Charles Vogel who put into words many things that I’ve been noticing about the communities that I was a part of. And he makes a distinction between group and community. While a group may share ideas, interests, proximity and so on, a community is a group of individuals that share a mutual concern for each other’s welfare. And this concern manifests itself in a shared set of values—a sense of shared identity with the task at hand. The GA4GH community is already a strong one, and it’s united by a powerful common goal. And when I was invited to chair the EDI group, I understood that the goal was not to change the community. Instead, it was the question of how to leverage the strengths of our community to ensure that it also represents the diversity that’s so important to the goals that we talked about earlier. The idea of an intentional community is to explicitly state who you want to be a part of it—rather than letting that happen organically. And then the principles are put into place to help strengthen the structures that support that intentional community, from how people are welcomed to be a part of it, to how we reinforce our values and responsibilities to each other, to how we enable individuals to deepen their commitment to the community.
Angela Page: How is the EDI group leveraging this idea of an intentional community to amplify underrepresented voices?
Laura Paglione: Well, we’re just getting started. But it is exciting to see and hear the thoughtfulness among the group that’s that is having the discussion so far. We’ve been talking about the community that participates in ga4gh activities today, and what voices might be absent right now that might enhance the work that we’re doing. We’ve been considering what the explicit and implicit community values and components of personal identity with the community and how those might affect those that are not yet participating. What I find encouraging is how many people in the group have remarked that just asking these questions have prompted a level of reflection that both brings us together in our EDI work and also reinforces our commitment to developing an inclusive community for GA4GH. From now through the plenary in September, we’re going to be inviting more of the community to reflect on those similar questions. And we’re hoping that others have a similar reaction. But to answer your question, the real work of amplifying underrepresented voices is still to come, as we discuss how to increase the number of underrepresented members in the community by identifying who’s missing and explicitly inviting them to participate, considering how we might increase their sense of inclusion in the community through intentional community characteristics of how we express belonging, reinforce inclusion, and value contributions, and considering how we might clarify how individuals that reflect that intentional community might increase their engagement through leadership and speaking opportunities.
Angela Page: To our listeners who are reflecting on this conversation right now, we want to encourage you to share your diverse perspective with the EDI group and with the GA4GH Work Streams as a whole.
Laura Paglione: I’m hoping the listeners already feel that there’s a space for their ideas and perspectives within the GA4GH Work Streams, where a majority of the work is done. But if they don’t feel that there’s a place for them, I sincerely hope they’ll be willing to join the EDI group to help us understand how the community might make room for their perspectives. I mean, we all have blind spots, and I definitely value those who illuminate what I don’t know, and in my short time with the EDI group, I’ve sensed that I’m not alone in this respect. So I’m hoping that the listeners will consider adding their perspectives, insights, and talents to GA4GH work.
Angela Page: And if anyone listening wants to get involved with the GA4GH EDI advisory group, you can reach out to us at info [at] www.ga4gh.org. This has been a really great conversation, and I’m so happy we got to speak with you today.
Laura Paglione: Thank you so much!
Thank you for listening to the OmicsXchange—a podcast of the Global Alliance for Genomics and Health. The OmicsXchange podcast is produced by Stephanie Li and Caity Forgey, with music created by Rishi Nag. GA4GH is the international standards org for genomics, aimed at accelerating human health through data sharing. I’m Angela Page and this is the OmicsXchange.